G. Aubert

1.5k total citations
53 papers, 1.0k citations indexed

About

G. Aubert is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, G. Aubert has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Molecular Medicine and 14 papers in Epidemiology. Recurrent topics in G. Aubert's work include Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (12 papers). G. Aubert is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (12 papers). G. Aubert collaborates with scholars based in France, United States and Algeria. G. Aubert's co-authors include Anne Carricajo, Abdesselam Zhiri, Nathalie Fonsale, Bruno Pozzetto, Fabrice Zéni, C. Auboyer, P. Berthelot, R. Jospé, F. Lucht and Jérémie Pourchez and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

G. Aubert

51 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Aubert France 18 249 247 197 160 160 53 1.0k
F. Bert France 15 262 1.1× 391 1.6× 95 0.5× 153 1.0× 218 1.4× 27 930
Rose Jung United States 18 310 1.2× 424 1.7× 219 1.1× 277 1.7× 89 0.6× 38 1.2k
D. Sofianou Greece 16 278 1.1× 616 2.5× 168 0.9× 160 1.0× 228 1.4× 39 1.1k
R E Warren United Kingdom 19 287 1.2× 276 1.1× 150 0.8× 89 0.6× 349 2.2× 42 1.1k
Halis Akalın Türkiye 15 378 1.5× 299 1.2× 131 0.7× 122 0.8× 196 1.2× 48 891
Heinrich K. Geiss Germany 20 259 1.0× 164 0.7× 111 0.6× 165 1.0× 262 1.6× 50 1.4k
E. J. Vollaard Netherlands 13 155 0.6× 127 0.5× 110 0.6× 225 1.4× 271 1.7× 29 810
E.E. Stobberingh Netherlands 16 362 1.5× 144 0.6× 60 0.3× 149 0.9× 116 0.7× 50 960
Anne Carricajo France 23 425 1.7× 218 0.9× 159 0.8× 241 1.5× 456 2.9× 72 1.6k
L. Stratchounski Russia 16 536 2.2× 609 2.5× 187 0.9× 120 0.8× 141 0.9× 25 1.2k

Countries citing papers authored by G. Aubert

Since Specialization
Citations

This map shows the geographic impact of G. Aubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Aubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Aubert more than expected).

Fields of papers citing papers by G. Aubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Aubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Aubert. The network helps show where G. Aubert may publish in the future.

Co-authorship network of co-authors of G. Aubert

This figure shows the co-authorship network connecting the top 25 collaborators of G. Aubert. A scholar is included among the top collaborators of G. Aubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Aubert. G. Aubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leclerc, Lara, Jérémie Pourchez, G. Aubert, et al.. (2014). Impact of Airborne Particle Size, Acoustic Airflow and Breathing Pattern on Delivery of Nebulized Antibiotic into the Maxillary Sinuses Using a Realistic Human Nasal Replica. Pharmaceutical Research. 31(9). 2335–2343. 31 indexed citations
2.
Durand, Mathieu, Sandrine Le Guellec, Jérémie Pourchez, et al.. (2012). Sonic aerosol therapy to target maxillary sinuses. European Annals of Otorhinolaryngology Head and Neck Diseases. 129(5). 244–250. 34 indexed citations
3.
Durand, Marc, Jérémie Pourchez, G. Aubert, et al.. (2011). Impact of acoustic airflow nebulization on intrasinus drug deposition of a human plastinated nasal cast: New insights into the mechanisms involved. International Journal of Pharmaceutics. 421(1). 63–71. 36 indexed citations
4.
Aubert, G., et al.. (2010). Prospective Determination of Serum Ceftazidime Concentrations in Intensive Care Units. Therapeutic Drug Monitoring. 32(4). 517–519. 32 indexed citations
5.
Ezingeard, Eric, et al.. (2009). Evaluation of colonisation of peripheral venous catheters inserted by prehospital emergency service teams (SMUR) in France. Journal of Hospital Infection. 72(2). 169–175. 6 indexed citations
6.
Carricajo, Anne, et al.. (2008). Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Letters in Applied Microbiology. 47(3). 167–173. 178 indexed citations
7.
Carricajo, Anne, C. Nuti, Eduardo Henrik Aubert, et al.. (2007). Propionibacterium acnes contamination in lumbar disc surgery. Journal of Hospital Infection. 66(3). 275–277. 64 indexed citations
8.
Berthelot, P., et al.. (2006). Outbreak of Postoperative Shoulder Arthritis Due to Propionibacterium acnes Infection in Nondebilitated Patients. Infection Control and Hospital Epidemiology. 27(9). 987–990. 30 indexed citations
9.
Carricajo, Anne, et al.. (2004). Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clinical Microbiology and Infection. 10(5). 459–461. 15 indexed citations
10.
Aubert, G., Anne Carricajo, Nathalie Fonsale, et al.. (2004). Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. Journal of Hospital Infection. 59(2). 83–89. 48 indexed citations
11.
Aubert, G. & Anne Carricajo. (2004). Place du laboratoire dans le choix et le suivi pharmacodynamique de l'antibiothérapie des infections sévères. Annales Françaises d Anesthésie et de Réanimation. 23(7). 704–713. 4 indexed citations
12.
Carricajo, Anne, Nathalie Fonsale, Florence Grattard, et al.. (2003). Contrôle de phénomènes épidémiques dus à des souches de Staphylococcus aureus de sensibilité diminuée aux glycopeptides. Pathologie Biologie. 51(8-9). 469–473. 2 indexed citations
13.
Berthelot, P., Florence Grattard, P Mahul, et al.. (2001). Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Medicine. 27(3). 503–512. 107 indexed citations
14.
Carricajo, Anne, et al.. (1999). Comparative Evaluation of Five Chromogenic Media for Detection, Enumeration and Identification of Urinary Tract Pathogens. European Journal of Clinical Microbiology & Infectious Diseases. 18(11). 796–803. 32 indexed citations
15.
16.
Aubert, G., Francine Grimont, Fabrice Zéni, et al.. (1995). Acinetobacter baumannii outbreak isolates characterized by three typing methods. European Journal of Clinical Microbiology & Infectious Diseases. 14(12). 1095–1099. 5 indexed citations
17.
Aubert, G., et al.. (1992). Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after flooroqmnolone therapy. Journal of Antimicrobial Chemotherapy. 29(3). 307–312. 39 indexed citations
18.
Aubert, G.. (1992). Apport du laboratoire de bactériologie dans les critères de choix et de surveillance d'un traitement antibiotique. Annales Françaises d Anesthésie et de Réanimation. 11(4). 454–460. 1 indexed citations
19.
Aubert, G., et al.. (1992). La teicoplanine : réflexion après 3 années d'utilisation. Médecine et Maladies Infectieuses. 22(4). 437–444.
20.
Aubert, G., et al.. (1990). [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].. PubMed. 48(7). 449–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Bert Breakdown of academic impact, for papers by Rose Jung Breakdown of academic impact, for papers by D. Sofianou Breakdown of academic impact, for papers by R E Warren Breakdown of academic impact, for papers by Halis Akalın Breakdown of academic impact, for papers by Heinrich K. Geiss Breakdown of academic impact, for papers by E. J. Vollaard Breakdown of academic impact, for papers by E.E. Stobberingh Breakdown of academic impact, for papers by Anne Carricajo Breakdown of academic impact, for papers by L. Stratchounski
Rankless by CCL
2026